Suppr超能文献

活体人类肾供体及其受体中表皮生长因子的尿排泄情况。

Urinary excretion of epidermal growth factor in living human kidney donors and their recipients.

作者信息

Jørgensen P E, Kamper A L, Munck O, Strandgaard S, Nexø E

机构信息

Department of Clinical Biochemistry, KH University Hospital of Aarhus, Denmark.

出版信息

Eur J Clin Invest. 1995 Jun;25(6):442-6. doi: 10.1111/j.1365-2362.1995.tb01727.x.

Abstract

Epidermal growth factor (EGF) is a growth-promoting peptide that is synthesized in the distal tubules of the kidney and excreted in urine. EGF has been suggested to play a role in the repair after renal tissue damage, as well as in compensatory growth of the remaining kidney after uninephrectomy. The present study examined the urinary EGF excretion after uninephrectomy and transplantation among relatives. The urinary EGF excretion rate and the glomerular filtration rate (GFR) were followed for 26-54 days in 16 healthy kidney donors and nine recipients. After uninephrectomy the median urinary EGF excretion rate in the donors was not 50% of the pre-operative value, but around 65% (95% confidence limits of the median on the fifth post-operative day: 59-72%). This suggests that there is a compensatory increase in the EGF excretion rate from the remaining kidney of around 30% after uninephrectomy. A similar compensatory increase was demonstrated for GFR, indicating that the compensatory changes in EGF excretion rate and GFR might be correlated. In the transplanted kidneys, GFR was consistently around 15% lower and EGF excretion rate around 40% lower than in the corresponding kidneys remaining in the donors. This might reflect ischaemic and drug-induced damage of the transplanted kidneys. The present study demonstrated a compensatory increase of around 30% in urinary EGF excretion from the remaining kidney after uninephrectomy in healthy humans. Whether EGF plays a role in the adaptive processes in the remaining kidney or whether changes in EGF excretion are merely of a secondary nature is still uncertain.

摘要

表皮生长因子(EGF)是一种促进生长的肽,在肾脏远曲小管中合成并随尿液排出。有人提出EGF在肾组织损伤后的修复以及单侧肾切除术后剩余肾脏的代偿性生长中发挥作用。本研究检测了亲属间单侧肾切除及肾移植后的尿EGF排泄情况。对16名健康肾脏供体和9名受体的尿EGF排泄率和肾小球滤过率(GFR)进行了26 - 54天的跟踪监测。单侧肾切除术后,供体的尿EGF排泄率中位数并非术前值的50%,而是约65%(术后第5天中位数的95%置信区间:59 - 72%)。这表明单侧肾切除术后,剩余肾脏的EGF排泄率有大约30%的代偿性增加。GFR也出现了类似的代偿性增加,表明EGF排泄率和GFR的代偿性变化可能相关。移植肾的GFR始终比供体中相应留存肾脏低约15%,EGF排泄率低约40%。这可能反映了移植肾的缺血性和药物性损伤。本研究表明,健康人单侧肾切除术后,剩余肾脏的尿EGF排泄量有大约30%的代偿性增加。EGF是否在剩余肾脏的适应性过程中发挥作用,或者EGF排泄的变化是否仅仅是继发性的,目前仍不确定。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验